Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|February 21, 1998
Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate in patients with advanced colorectal cancer. Results of a phase II studyC H Köhne, A Harstrick, W Hiddemann, et al.
Seminars in Oncology|December 1, 1995
Phase I/II study with paclitaxel in combination with weekly high-dose 5-fluorouracil/folinic acid in the treatment of metastatic breast cancer: an interim analysisU Klaassen, H Wilke, C P Pari, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 1, 1997
[An interdisciplinary consensus conference on the diagnosis and therapy of testicular tumors]M Bamberg, H J Schmoll, L Weissbach, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1996
A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumorsC Bokemeyer, O Köhrmann, J Tischler, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancerH Wilke, P Preusser, M Stahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancerC Bokemeyer, A Gerl, P Schöffski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancerC Bokemeyer, J Beyer, B Metzner, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Deficient repair of cisplatin-DNA adducts identified in human testicular teratoma cell lines established from tumours from untreated patientsB T Hill, K J Scanlon, J Hansson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 1997
Modulation of 5-fluorouracil with methotrexate and low-dose N-(phosphonacetyl)-L-aspartate (PALA) is inactive in advanced pancreatic carcinomaA Harstrick, C H Köhne, W Hiddemann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 5, 2003
Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I studyM Tewes, N Schleucher, W Achterrath, et al.
Pageof 9